"A recent study shows an abnormal diffuse inflammatory cytokine profile that persists in Long COVID patients for at least 8 months, not found in asymptomatic COVID-19 survivors.
Studies of Long COVID patients have shown persistent deregulation of a broad range of cytokines long after infection. Specifically, it is shown that IL-1β, IL-6 and TNF-α remain elevated in Long COVID - PASC. This is despite the fact that peripheral blood cytokines do not need to be elevated, since they function by acting locally rather than by flowing through the blood. Nevertheless, persistent immune activation has been suggested to be associated with ongoing symptoms following COVID-19."
https://www.frontiersin.org/articles/10.3389/fmed.2023.1011936/full#:~:text=A%20recent%20study%20shows%20an,of%20cytokines%20long%20after%20infection.
=> Remestemcel-L POSSIBLY helping with long-COVID too....
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-904
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $4.551M | 3.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 98246 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 19079 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |